1. Introduction {#s0005}
===============

Nitrite (NO~2~^-^) is a dietary constituent and intrinsic signaling molecule that mediates a number of physiological and cytoprotective effects. It is now accepted that nitrite represents an endocrine reservoir of nitric oxide (NO) in blood and tissues which can be reduced to bioavailable NO through a reaction that is catalyzed by a host of heme and molybdenum containing proteins in hypoxic conditions [@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6]. Nitric oxide generated via nitrite reduction activates canonical soluble guanylate cyclase signaling or propagates further anhydrase chemistry resulting in the S-nitrosation of protein targets to mediate biologic effects [@bib7], [@bib8], [@bib9]. While the majority of nitrite\'s effects are dependent on its reduction to NO, several studies have demonstrated NO independent actions of nitrite [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15]. However, the chemistry underlying this signaling remains less clear.

Dinitrosyliron complexes (DNIC) have been reported to be the most abundant NO-derived adduct in the cell [@bib16]. These complexes, comprised of non-heme iron, two nitrosyl groups and thiol-containing ligands, are formed rapidly in the presence of low concentrations of free NO and persist in the cell long after the disappearance of NO production [@bib16], [@bib17]. While nitrite is known to form DNIC, the formation of this species by nitrite versus NO has not been compared [@bib18], [@bib19], [@bib20]. Further, DNIC have been reported to have both cytoprotective and cytotoxic roles physiologically, but it remains unclear whether DNIC formation contributes to biological effects mediated by nitrite [@bib16], [@bib18], [@bib21], [@bib22], [@bib23], [@bib24].

One of the most reproducible and potent effects of nitrite is its ability to confer cytoprotection after ischemia/reperfusion (I/R) in cellular models and a number of organs including the heart, brain, kidney, lung and liver [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30]. Mechanistically, this protection is dependent on the reduction of nitrite and the subsequent S-nitrosation of a critical cysteine residue in complex I of the mitochondrion. This modification leads to inhibition of complex I enzymatic activity, resulting in attenuation of reperfusion mitochondrial oxidant production, preventing downstream apoptosis [@bib31], [@bib32]. Notably, recent studies have implicated the formation of mitochondrial DNIC in nitrite-mediated protection after I/R [@bib18]. Separate studies have shown that DNIC formation is potentiated during prolonged cellular hypoxia and that DNIC can be converted to S-nitrosothiols (SNO) [@bib18], [@bib21], [@bib33], [@bib34]. Thus, we sought to determine whether nitrite-dependent DNIC formation in mitochondria contributes to nitrite-mediated protection after I/R.

Our data confirm that DNIC are formed by chronic dietary nitrite supplementation but show that this formation is not associated with the protective effect of nitrite. We compare NO and nitrite-dependent DNIC formation in isolated mitochondria and demonstrate that DNIC formation occurs concomitant with NO-induced mitochondrial damage. These results demonstrate that nitrite-dependent DNIC formation is physiologically relevant and highlight a mechanistic difference between NO and nitrite mediated signaling. This is discussed in the context of the pathological role of DNIC and its implication for nitrite versus NO-dependent mitochondrial regulation and hypoxic signaling.

2. Methods {#s0010}
==========

2.1. Chemicals {#s0015}
--------------

All chemicals were purchased from Sigma-Aldrich unless otherwise noted.

2.2. Animals {#s0020}
------------

All animal studies were performed in accordance with and approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. For nitrite supplementation studies, C57/Bl6 mice (8--10 week old males) were maintained on a standard diet and autoclaved water. Water was supplemented with 0, 0.3, 1.5, or 3.0 g/L of sodium nitrite and mice were allowed to drink ad libitum. Mitochondria were isolated from male Sprague Dawley rats (250--500 g).

2.3. Hepatic I/R {#s0025}
----------------

Liver I/R was performed as previously described [@bib32]. Briefly, after nitrite supplementation, mice were anesthetized with intraperitoneal injections of ketamine (100 mg/kg) and xylazine (8 mg/kg). A midline laparotomy incision was performed, and mice were heparinized (100 μg/kg). The hepatic artery and portal vein were completely clamped to cause ischemia of the left lateral and median lobes of the liver. The liver was kept moist with normal saline for 45 min, after which the clamp was removed to reperfuse the liver. Mice were sutured, and plasma collected 5 h later for measurement of alanine transaminase levels.

2.4. DNIC measurement {#s0030}
---------------------

Tissue and mitochondrial samples were collected and immediately flash frozen in EPR tubes. All samples were shipped between labs on dry ice and stored in liquid nitrogen. Measurements were performed on a Bruker X-band EMX Plus EPR spectrometer. All samples were read in liquid nitrogen and were not thawed at any point before measurement. Dinitrosyliron complexes (DNIC) were detected at *g* = 2.03. Settings were as follows: centerfield 3335.25 G, microwave frequency 9.460544 GHz, modulation amplitude 10 G, 200 G scan range, 90-s scan time, one scan. For quantification, amplitude of signal from 2.04 to 2.02 was compared with amplitude of a standard curve generated with synthetic diglutathione DNIC as described previously [@bib16], [@bib23].

2.5. S-nitrosothiol and iron-nitrosyl measurement {#s0035}
-------------------------------------------------

S-nitrosothiol concentration was measured by tri-iodide based reductive chemiluminescence using a Nitric Oxide Analyzer (Sievers) as previously described [@bib32], [@bib35]. Briefly, each sample was divided and treated with either acidified sulfanilamide (16% in 2 M HCl) or with mercuric chloride. Each treated sample was injected into tri-iodide and the area under the curve measured, and concentration quantified using a standard curve of known concentrations. SNO concentration was the calculated as the difference between the acid sulfanilamide and mercuric chloride treated samples. Iron-nitrosyl concentration was measured by injecting untreated samples into potassium ferricyanide (0.1 M). NO released from the Fe-NO was measured by chemiluminescence [@bib35].

2.6. Mitochondrial Isolation {#s0040}
----------------------------

Rat liver mitochondria were isolated by differential centrifugation as previously described [@bib32], [@bib35].

2.7. In vitro anoxia/reoxygenation {#s0045}
----------------------------------

The in vitro anoxia/reoxygenation protocol was performed as previously described [@bib32]. Briefly, mitochondria were suspended in respiration buffer(120 mM KCl, 25 mM sucrose, 10 mM Hepes, 1 mM EGTA, 1 mM KH~2~PO~4~, 5 mM MgCl~2~) in a stirred, sealed chamber fit with a Clark-type oxygen electrode (Instech Corp.) connected to a data recording device (DATAQ Systems). State 3 respiration was initiated and mitochondria were allowed to consume oxygen until the chamber became anoxic. Nitrite or NO was added to the chamber once it reached anoxia. The mitochondria were left in anoxia for 30 min, after which the mitochondria were centrifuged and resuspended in oxygenated buffer containing fresh substrate and ADP, and allowed to respire once again. Post-anoxic respiratory rate was expressed as a percentage of pre-anoxic rate and called recovery of respiration.

2.8. Aconitase activity {#s0050}
-----------------------

Mitochondria were lysed by three cycles of freeze/thaw, and aconitase activity was measured by spectrophotometrically monitoring the formation of NADPH at 340 nm using the Bioxytech Aconitase-340 kit (Oxis Research).

### 2.8.1. Statistics {#s0055}

Values are expressed as means ± SEM of at least 3 independent experiments. Single comparisons were tested for significance using a two-tailed Student\'s *t*-test. Multiple comparisons were made using ANOVA followed by the Bonferroni post hoc test. P\<0.05 was considered significant.

3. Results {#s0060}
==========

In the first series of experiments, we tested whether oral nitrite administration resulted in DNIC formation in vivo. Mice were fed nitrite supplemented water (3 g/L) ad libitum for seven days and DNIC levels were measured in the heart, liver, kidney and brain. A significant DNIC signal was detected by EPR in kidney tissue, while no signal was measured in the brain ([Fig. 1](#f0005){ref-type="fig"}**A-B**). The greatest concentration of DNIC was measured in the liver and thus, we decided to focus our studies on this organ. DNIC signal was undetectable in any organ from mice not supplemented with nitrite (data shown for liver in [Fig. 1](#f0005){ref-type="fig"}**C**).Fig. 1**Oral nitrite supplementation results in DNIC formation. (A)** Representative EPR traces demonstrating DNIC formation (denoted with an arrow) in the liver, kidney and brain of mice after oral nitrite supplementation on day 3. **(B)** Quantification of DNIC from several traces such as those shown in **(A). (C)** Representative EPR traces demonstrating DNIC formation in the liver of mice supplemented with nitrite (3 g/L) for 0,1,3, or 7 days or after one hour of an intraperitoneal nitrite (260 µg/kg) injection. **(D)** S-nitrosothiol and **(E)**heme-nitrosyl concentrations in the liver of mice supplemented as described in panel C. All values are mean ± SEM. n = 5; \*p \< 0.01.Fig. 1

Measurement of the time course of liver DNIC formation confirmed prior studies demonstrating that DNIC were detectable only after three or more days of nitrite supplementation [@bib19], [@bib36] ([Fig. 1](#f0005){ref-type="fig"}**C**). Since NO-dependent DNIC formation has been shown to be rapid in cell culture systems [@bib16], we administered one intraperitoneal injection of nitrite (260 µg/kg) and measured liver DNIC one hour later. This dose of nitrite acutely increased plasma nitrite levels to \~12 µM, however DNIC were not detectable at this time point ([Fig. 1](#f0005){ref-type="fig"}**C**). Notably, concentrations of S-nitrosated ([Fig. 1](#f0005){ref-type="fig"}**D**) and iron-nitrosylated ([Fig. 1](#f0005){ref-type="fig"}**E**) proteins were increased after the IP injection, demonstrating that nitrite was metabolized in the liver. S-nitrosothiols and iron-nitrosyls were also present in the absence of DNIC after one day of oral nitrite supplementation and their concentration plateaued after 3 days of supplementation, concomitant with the appearance of DNIC ([Fig. 1](#f0005){ref-type="fig"}**C-E**).

We and others have previously demonstrated that nitrite-mediated cytoprotection after ischemia/reperfusion (I/R) is dependent on S-nitrosation of mitochondrial complex I [@bib31], [@bib32]. Prior studies have also suggested that mitochondrial DNIC formation is protective in *ex vivo* models of hypoxia-reoxygenation [@bib18], and that DNIC can be converted to SNO [@bib33], [@bib34]. Thus, we next sought to determine whether nitrite-dependent DNIC formation was associated with S-nitrosation and nitrite-dependent cytoprotection after I/R. Mice were placed on nitrite supplemented water (0--3 g/L) for three days and then subjected to hepatic artery/portal vein ligation as a model of hepatic I/R. As expected, supplementation with nitrite increased plasma nitrite levels from 103 ± 16 nM (untreated group) to 360 ± 43 nM, 567 ± 40 nM, and 780 ± 48 nM in the mice supplemented with 0.3, 1.5, and 3 g/L nitrite respectively. Consistent with prior studies [@bib37], measurement of plasma alanine aminotransferase (ALT) levels six hours after I/R showed that 0.3 and 1.5 g/L of nitrite mediated significant liver protection after I/R, while no protection was observed with nitrite at the highest dose (3 g/L) ([Fig. 2](#f0010){ref-type="fig"}**A**). Measurement of NO adducts in the liver showed a dose dependent increase in iron-nitrosyl concentration ([Fig. 2](#f0010){ref-type="fig"}**B**) with increasing nitrite as well as increased liver SNO ([Fig. 2](#f0010){ref-type="fig"}**C**). However, DNIC was detectable only at the highest dose of nitrite ([Fig. 2](#f0010){ref-type="fig"}**D**). These data demonstrate that tissue SNO and Fe-NO accumulates at lower concentrations of nitrite than DNIC, and that DNIC accumulation is not significant at cytoprotective doses of nitrite in vivo.Fig. 2**DNIC formation is not associated with nitrite-dependent attenuation of hepatic I/R injury.** Mice were orally supplemented with nitrite (0--3 g/L in the water) or nitrite (3 g/L) and then subjected to hepatic I/R. **(A)** Plasma alanine aminotransferase levels 6 h after I/R. **(B-C)** Concentration of **(B)** Fe-NO and **(C)** RSNO in the liver tissue 6 h after I/R. **(D)** Representative EPR traces showing DNIC formation (denoted with arrow) in the liver 6 h after I/R. All values are mean ± SEM. n = 5; \*p \< 0.01.Fig. 2

Given the essential role of the mitochondrion in the mechanism of nitrite-mediated protection after I/R and the prior evidence of in vitro mitochondrial DNIC formation during anoxia [@bib18], [@bib22], we examined whether dietary nitrite supplementation resulted in mitochondrial DNIC formation. Fractionation of liver tissue from nitrite supplemented (3 g/L) mice showed that significant DNIC was formed in the mitochondrial compartment ([Fig. 3](#f0015){ref-type="fig"}**A**). To more directly probe the role of mitochondrial DNIC formation, we utilized isolated mitochondria to compare DNIC formation by nitrite and NO and its effect on mitochondrial protection in hypoxia. Isolated liver mitochondria were treated in anoxic conditions with equal equivalents of either nitrite (0--1 mM) or NO (donor DEANONOate; DEANO; 0--500 µM). Notably, NO and nitrite showed distinctly different profiles of DNIC formation. DNIC levels were similar between DEANO and nitrite at low concentrations of NO equivalents (10 and 50 µM). At increasing concentrations, however, the levels of mitochondrial DNIC remained constant for nitrite but continually increased in response to NO ([Fig. 3](#f0015){ref-type="fig"}**B-D**). Both NO and nitrite-dependent mitochondrial SNO ([Fig. 3](#f0015){ref-type="fig"}**E**) and Fe-NO ([Fig. 3](#f0015){ref-type="fig"}**F**) levels showed a concentration dependent increase demonstrating that DNIC formation was not limited by the lack of nitrite to NO conversion in the mitochondrion.Fig. 3**NO forms DNIC more efficiently than nitrite in the mitochondrion. (A)** A representative EPR trace showing the DNIC signal in liver mitochondria from mice supplemented (red) or not (black) with nitrite (3 g/L in the water). **(B-C)** Representative EPR traces demonstrating DNIC levels in isolated rat liver mitochondria treated with **(B)** DEANONOate (0--500 µM) or **(C)** nitrite (0--1 mM) in anoxic conditions. **(D)** Quantitation of DNIC from traces similar to those shown in (B-C). **(E-F)** Concentrations of **(E)** S-nitrosothiol and **(F)** Fe-NO in the same livers as (B-C). All values are mean ± SEM. n = 5; \*p \< 0.01.Fig. 3

To test whether mitochondrial DNIC formation was associated with mitochondrial protection, we subjected the isolated mitochondria to an in vitro assay of anoxia/reoxygenation which has previously been shown to mimic mitochondrial damage observed during tissue ischemia/reperfusion [@bib32]. In this assay, mitochondrial respiration is decreased after anoxia due to oxidative damage, and greater recovery of respiration after an anoxic period is indicative of mitochondrial protection. [Fig. 4](#f0020){ref-type="fig"}**A** demonstrates that treatment with either nitrite or NO during the anoxic period mediated a biphasic protection curve. Both molecules were significantly protective at low concentrations (10--50 µM NO equivalents). However, while NO lost its protective effect at 100 µM NO equivalents and induced damage at higher concentrations, nitrite maintained protection at 100 µM and did not cause damage at any concentration ([Fig. 4](#f0020){ref-type="fig"}**A**). Notably, the lack of protection at 100 µM NO equivalents coincides with the plateau in SNO formation by both molecules ([Fig. 3](#f0015){ref-type="fig"}**E**), and the damage induced by DEANO is concomitant with its significant increase in DNIC formation compared to nitrite ([Fig. 3](#f0015){ref-type="fig"}**D**).Fig. 4**High concentrations of nitrite and NO have differing effects on mitochondrial protection. (A)** Recovery of respiration and **(B)** aconitase activity of isolated mitochondria subjected to anoxia/reoxygenation in the presence of either DEANONOate (0--500 µM) or nitrite (0--1 mM) compared to mitochondria that were not subjected to anoxia/reoxygenation (Norm). All values are mean ± SEM. n = 7; \*p \< 0.01 versus corresponding 0 µM treatment. ^§^p \< 0.01 versus same NO equivalents.Fig. 4

Mitochondrial aconitase is an iron-sulfur protein that is a major target for oxidation, resulting in the loss of its activity. Additionally, its iron centers have previously been identified as a potential target for DNIC formation [@bib20], [@bib22]. Measurement of aconitase activity in the isolated mitochondria subjected to anoxia/reoxygenation showed that aconitase activity was significantly decreased after anoxia/reoxygenation ([Fig. 4](#f0020){ref-type="fig"}**B**), consistent with prior reports [@bib32]. Low concentrations of both nitrite and NO attenuated the loss in aconitase activity, potentially due to decreased oxidative stress. While higher concentrations of nitrite also prevented anoxia-induced loss of aconitase activity, concentrations of DEANO above 250 µM decreased aconitase activity ([Fig. 4](#f0020){ref-type="fig"}**B**).

4. Discussion {#s0065}
=============

The main findings of this study are that 1) dietary nitrite supplementation results in hepatic mitochondrial DNIC formation in vivo, 2) NO and nitrite mediate differential profiles of mitochondrial DNIC formation in vitro and 3) high concentrations of NO-dependent DNIC formation are associated with the potentiation of anoxic mitochondrial damage.

Our data demonstrate that DNIC form in vivo predominantly in the liver and only with higher concentrations (3 g/L) or longer duration (3 days) of nitrite supplementation. These data are very consistent with prior studies by Vanin and colleagues who measured \~10nmol DNIC/g of liver tissue in rats after administering 0.3% nitrite for three days in the drinking water [@bib19]. While prior studies have shown that the formation of DNIC in isolated tissues and cells is rapid [@bib16], [@bib18], [@bib38], our in vivo model demonstrated accumulation of SNO and Fe-NO much earlier than DNIC. *In vitro* studies demonstrate that DNIC contribute to SNO formation through transnitrosation reactions [@bib21], [@bib33], [@bib34]. It is possible that nitrite forms tissue DNIC which are rapidly converted to SNO, such that DNIC do not accumulate at detectable levels (by EPR) until targets for S-nitrosation are saturated. Alternatively, the converse is possible in which SNO form first and subsequently participate in DNIC assembly by directly contributing the NO and thiol ligands or liberating free NO that reacts with iron [@bib39]. Notably, Asanuma and colleagues have shown more rapid DNIC formation that appears in 2--8 h after nitrite/nitrate supplementation. However, this signal is detected in the acidic environment of the gastric tissue, which potentially lends itself to greater nitrite/nitrate reduction than other tissues [@bib20]. While we did not measure DNIC levels in the gut in this study, the results presented here further highlight the necessity to consider the role of DNIC formation in nitrite signaling. This is particularly important given that 30--40% of endogenous tissue nitrite is derived from dietary intake of nitrite and nitrate, and that oral nitrite/nitrate supplementation is being explored as a strategy for a number of pathologies including hypertension and atherosclerosis [@bib40], [@bib41], [@bib42]. Relevant to the use of nitrite/nitrate as a potential therapeutic, the plasma nitrite concentrations achieved in the present study (\~0.3--0.6 µM), particularly at the lower supplementation groups (0.3 and 1.5 g/L nitrite) are within the range that has been shown to protect against I/R injury in other animal models [@bib25], [@bib27], [@bib28], [@bib29], [@bib32], [@bib43] as well as lower blood pressure [@bib42], [@bib44], attenuate platelet aggregation in response to stimuli [@bib42], improve vascular function [@bib41], and increase exercise efficiency [@bib45], [@bib46] in humans.

While prior studies have demonstrated nitrite-dependent DNIC formation in whole tissues in vitro and in vivo [@bib18], [@bib19], the subcellular localization of DNIC within the tissue has not been explored. Here we show for the first time that significant levels of DNIC accumulate within the mitochondrion in vivo after dietary nitrite supplementation ([Fig. 3](#f0015){ref-type="fig"}**A**). Interestingly, prior studies have suggested that oral nitrite supplementation leads to DNIC formation predominantly in the extracellular compartment [@bib19]. While mechanisms of cellular DNIC transport have been reported [@bib24], it remains unknown whether the mitochondrion can import pre-formed DNIC in intact cells or tissue. However, our data demonstrating nitrite-dependent DNIC formation in isolated mitochondria are consistent with *de novo* DNIC formation within the organelle rather than import. While the exact proportion of tissue DNIC that accumulates within the mitochondrion is unclear, it is well established that the organelle contains a pool of free iron that potentially contributes to DNIC formation [@bib18], [@bib22]. Further, nitrite has been shown to enter the mitochondrion, where it can be reduced to NO by a number of proteins including cytochrome c or cytochrome c oxidase [@bib47], [@bib48]. Indeed our data demonstrating the formation of SNO and Fe-NO show that DNIC formation is concomitant with reduction of nitrite. Regardless of the mechanism of formation, the data presented herein establish the mitochondria as a physiological target of DNIC action.

It is intriguing that though nitrite and NO mediate similar levels of other NO-dependent protein modifications (SNO and Fe-NO), NO generates significantly more DNIC than nitrite. Levels of SNO and Fe-NO begin to plateau around 100 µM NO equivalents. In contrast, DNIC concentration increases dose dependently with increasing NO donor treatment while no change in DNIC is observed with changing nitrite concentrations. The lower levels of DNIC formation by nitrite versus NO is likely due to the exhaustion of nitrite reductase proteins, leading to the inability to convert increasing concentrations of nitrite to NO in order to form DNIC. While further kinetic study is required to determine why no concentration dependent increase in nitrite-dependent DNIC formation is observed, it is interesting to speculate that perhaps while the mitochondrial chelatable iron pool is a greater or equivalent target to heme and thiol containing proteins for NO, nitrite selectively modifies proteins that reduce nitrite or are in close proximity to nitrite reducing proteins before reacting with free iron.

DNIC have been associated with both cytoprotective and pathogenic effects in cell and animal systems. Cytoprotective effects of the species have predominantly been reported to be due its antioxidant capabilities. For example, Li and colleagues demonstrated that NO-dependent DNIC formation attenuated free-iron catalyzed Fenton chemistry in an in vitro model of cellular anoxia [@bib21]. Dungel and colleagues demonstrated a similar protective phenomenon by nitrite-dependent DNIC formation in an anoxic isolated mitochondrial system supplemented with free iron [@bib18]. In contrast, other reports have associated DNIC formation with cytotoxicity and pathogenesis. Mechanistically, cytotoxicity has been attributed to the disruption of iron containing enzymes, such as the iron-sulfur protein aconitase [@bib16], [@bib20], [@bib22], [@bib36]. Our data could be consistent with both a protective and toxic effect of DNIC. Importantly, Hickok and colleagues demonstrated in a murine macrophage model that DNIC formation becomes cytotoxic only once it exceeds the concentration of the chelatable iron pool [@bib16]. This paradigm is likely applicable to the data presented here. In the case of nitrite and lower concentrations of NO (\<100 µM DEANO), DNIC formation may contribute to mitochondrial protection after anoxia/reoxygenation through an antioxidant mechanism. However, in the case of the NO donor, once greater levels of DNIC formation are achieved (\>100 µM NO treatment), aconitase activity begins to decrease (consistent with disruption of iron-sulfur centers) and injury is potentiated. Notably, while nitrite-dependent mitochondrial protection peaks at 50 µM NO equivalents, higher concentrations of nitrite neither disrupt aconitase activity nor injure the mitochondrion. Similarly, in the in vivo hepatic I/R model, nitrite-derived Fe-NO and RSNO are associated with protection only in the absence of DNIC (\<3 g/L; [Fig. 2](#f0010){ref-type="fig"}). While these data suggest that DNIC potentiate mitochondrial injury only once the free iron pool is exhausted, measurement of the mitochondrial chelatable iron pool will be required to test this concept fully.

In summary, our in vivo data confirm that dietary nitrite supplementation generates DNIC in the liver and demonstrates a measurable proportion of these DNIC are localized within the mitochondrion. *In vitro* studies show that at the mitochondrial level NO generates greater concentrations of DNIC than nitrite, and high DNIC concentration is associated with the loss of aconitase activity and potentiation of anoxia-induced mitochondrial injury. These data demonstrate another significant difference between nitrite and NO signaling and highlight the importance of considering DNIC formation in the context of nitrite-dependent signaling and therapeutics.
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